Last reviewed · How we verify
Chronic Musculoskeletal Pain
Approved treatments
- Cymbalta · Eli Lilly and Company
Potentiates serotonergic and noradrenergic activity in the CNS through unknown exact mechanisms.
Clinical guidelines
- FDA label — 1L
Duloxetine is indicated for the treatment of chronic musculoskeletal pain in adults.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic Musculoskeletal Pain patent landscape — cliff calendar, originator estates, attackable patents
- Chronic Musculoskeletal Pain treatment landscape brief
- Chronic Musculoskeletal Pain treatment updates RSS
Frequently asked questions about Chronic Musculoskeletal Pain
What drugs treat Chronic Musculoskeletal Pain?
Tracked treatments include Cymbalta.
What is the treatment for Chronic Musculoskeletal Pain?
Standard treatment for Chronic Musculoskeletal Pain includes Cymbalta. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Chronic Musculoskeletal Pain?
FDA label publishes guidelines for Chronic Musculoskeletal Pain. 1 guideline references tracked.
Related
- Treatment landscape: Chronic Musculoskeletal Pain patent cliff · Chronic Musculoskeletal Pain CI report
- Treatment: Cymbalta · Eli Lilly and Company
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing